Evidence map›Paper›PMID 29921235›Full record

ArticleBMC cancer2018

TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.

Justin Zonneville, Alfiya Safina, Alexander M Truskinovsky, Carlos L Arteaga, Andrei V Bakin

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Signaling Role of Pericytes in Vascular Health and Tissue Homeostasis.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. TNFSF15 facilitates the differentiation of CD11bCancer biology & medicine · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Justin ZonnevilleDepartment of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA.
Alfiya SafinaDepartment of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Alexander M TruskinovskyDepartment of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Carlos L ArteagaHarold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Andrei V BakinDepartment of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA. andrei.bakin@roswellpark.org.ORCID http://orcid.org/0000-0002-7728-1969
Roswell Park Comprehensive Cancer Center · USSouthwestern Medical Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Mechanisms of TGFbeta-mediated fibroblastic transitionR01CA095263 · NCI · VANDERBILT UNIVERSITY · PI BAKIN, ANDREI · 2002 to 2006
$1.6M
Defense Health Agency BC151886National Cancer Institute CA16056National Cancer Institute CA95263NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA095263
6 · The paper itself

Abstract

backgroundThe breast cancer microenvironment promotes tumor vascularization through the complex interactions involving tumor-associated fibroblasts (TAFs). Emerging data indicate that TAFs increase production and signaling by TGF-β cytokines, while the role of TGF-β signaling in the regulation of tumor blood vessels is not fully understood. The current study presents evidence that TAFs enhance the organization of tumor blood capillaries, and TGF-β signaling plays an important role in this response.

methodsTumor vascularization was studied in xenograft models of breast carcinoma cells, alone and in combination with fibroblasts. TGF-β signaling in breast cancer cells was modulated by expression of kinase-inactive TGFBR1-K232R (dnTGFBR1) or constitutive-active TGFBR1-T204D (caTGFBR1) receptor mutants. The architecture of tumor blood capillaries was assessed by immune-histochemical analysis of endothelium and pericytes. The role of TGF-β-Smad signaling in fibronectin expression was examined using adenoviral transduction of signaling components.

resultsOur studies revealed that TAFs significantly increase the lumen size of blood microvessels. Inactivation of TGF-β signaling in tumor cells by dnTGFBR1 reduced the microvessel density and lumen sizes, decreasing tumor growth. In contrast, caTGFBR1-tumors exhibited greater vessel density and lumen sizes. Tumors with inactive dnTGFBR1 showed lower amounts of TAFs, while caTGFBR1 increased amounts of TAFs compared to the control. Inspection of pericytes and endothelial cells in tumor vasculature revealed that TAFs enhanced vessel coverage by pericytes, vascular cells supporting capillaries. This effect was impaired in dnTGFBR1-tumors, whereas active caTGFBR1 enhanced the association of pericytes with endothelium. Accordingly, dnTGFBR1-tumors exhibited the presence of hemorrhages, a sign of fragile blood vessels. Biochemical analysis showed that TGFBR1-SMAD signaling up-regulates fibronectin, a prominent regulator of endothelium-pericyte interactions.

conclusionsThe current study indicates that tumor-fibroblast crosstalk enhances tumor vascularization by increasing the pericyte-endothelium association via a mechanism involving the TGFβ-fibronectin axis. The tumor-fibroblast model represents a useful system for dissecting the complex interactions governing tumor angiogenesis and developing new approaches to therapeutic targeting tumor vasculature.

Indexed as

AnimalsBreast NeoplasmsCancer-Associated FibroblastsEndothelium, VascularFemaleHeterograftsHumansMiceMice, SCIDNeovascularization, PathologicPericytesSignal TransductionTransforming Growth Factor betaTumor MicroenvironmentTransforming Growth Factor betaBreast cancerFibronectinPericytesTGF-betaTumor angiogenesisTumor-associated fibroblastsTumor microenvironment

Identifiers

PMID29921235
PMCPMC6008941
OpenAlexW2808762250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.